Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.00 (0.00%)
Bid:
102.00
Ask:
106.00
Spread: 4.00 (3.922%)
Market Cap: £61.92m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Shareholder returns update

12 Apr 2023 07:05

RNS Number : 8844V
Crystal Amber Fund Limited
12 April 2023
Β 

12 April 2023

CRYSTAL AMBER FUND LIMITED

("Crystal Amber Fund" or the "Fund")

Β 

Shareholder returns update

Within the Fund's interim results for the six months to 31st December 2022 published last month, it was stated that the Board remains optimistic that the Fund will return significant disposal proceeds to shareholders in the second half of 2023, and that this will be principally determined by the outcome of the current recommended acquisition of Hurricane Energy plc ("Hurricane").

Β 

The Board notes that on 6 April 2023, Hurricane published a circular in relation to the recommended acquisition of the entire issued, and to be issued, share capital of Hurricane by Prax (the "Acquisition") to be effected by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme") setting out the full terms and conditions of the Scheme and an expected timetable of events (the "Scheme Document"). In addition to Court and Hurricane shareholder approval, the Scheme is also subject to satisfaction (or, where applicable, waiver) of the other conditions set out in the Scheme Document, including approval from the North Sea Transition Authority ("NSTA") and approval under the United Kingdom National Security and Investment Act 2021 ("NSIA"), and the approval of the Court. The Scheme is expected to become effective in Q2 2023.

Β 

A meeting of Hurricane shareholders to approve the Scheme has been set for 4 May 2023. Cash consideration due under the Scheme and payment of special dividends due pursuant to the Scheme are scheduled within 14 days of the Scheme becoming effective. The cash consideration due to the Fund upon the Scheme becoming effective is Β£34.7 million, equivalent to 41.6p per Crystal Amber share ("the Initial Consideration"). In addition, the Fund could receive deferred consideration units with a value up to Β£37.3 million, equivalent to an additional 44.8p per Crystal Amber share. The total potential consideration due relating to the sale of the Fund's shareholding in Hurricane would be Β£72 million, equivalent to 86.5p per Crystal Amber share.

Β 

Upon the Scheme receiving Hurricane shareholder and Court approval on 4 May 2023, the Fund intents to consult with major shareholders regarding the treatment of the disposal proceeds. The Fund intends to announce a substantial return of capital, as soon as practical, with a view to returning capital immediately after the receipt of the Initial Consideration. As previously announced, the Fund intends to retain sufficient liquidity out of the Initial Consideration to continue to fund growth at GI Dynamics and protect the value of its holding in De La Rue.

Β 

Earlier today Crystal Amber announced that the net asset value per share on 31 March 2023 was 117.4p. This comprises 49.1p per share relating the holding in Hurricane and a net 68.3p for the Fund's other assets and liabilities. On the assumption that the full consideration relating to Hurricane of 86.5p per Crystal Amber share had been received on 31 March 2023, the pro forma net asset value per share on 31 March 2023 would have increased by 37.4p per share to 154.8p per Crystal Amber share.

Β 

A further announcement will be made in due course.

Β 

For further enquiries please contact:

Β 

Crystal Amber Fund Limited

Chris Waldron (Chairman)

Tel: 01481 742 742

www.crystalamber.com

Β 

Allenby Capital Limited - Nominated Adviser

David Worlidge/Jeremy Porter/Dan Dearden-Williams

Tel: 020 3328 5656

Β 

Winterflood Investment Trusts - Broker

Joe Winkley/Neil Langford

Tel: 020 3100 0160

Β 

Crystal Amber Advisers (UK) LLP - Investment Adviser

Richard Bernstein

Tel: 020 7478 9080

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCFLFLDSAILLIV
Date   Source Headline
22nd May 20261:07 pmRNSMonthly Net Asset Value
6th May 202612:54 pmRNSPurchase of Ordinary Shares by Tarncourt
30th Apr 20265:00 pmRNSTotal Voting Rights
22nd Apr 20262:54 pmRNSMonthly Net Asset Value
22nd Apr 20269:47 amRNSResult of EGM
16th Apr 20265:19 pmRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20265:03 pmRNSTransaction in Own Shares and Total Voting Rights
8th Apr 202610:51 amRNSTransaction in Own Shares and Total Voting Rights
1st Apr 20265:41 pmRNSDirector/PDMR Shareholding
31st Mar 20265:00 pmRNSTotal Voting Rights
31st Mar 20267:01 amRNSHalf-year Report
31st Mar 20267:00 amRNSPosting of Circular and Notice of EGM
26th Mar 20264:25 pmRNSMonthly Net Asset Value
16th Mar 20264:29 pmRNSNotice of results; update re strategy and manager
2nd Mar 202611:49 amRNSMonthly Net Asset Value
2nd Mar 202611:30 amRNSTotal Voting Rights
25th Feb 20266:17 pmRNSTransaction in Own Shares and Total Voting Rights
24th Feb 20265:26 pmRNSTransaction in Own Shares and Total Voting Rights
20th Feb 20265:44 pmRNSTransaction in Own Shares and Total Voting Rights
18th Feb 20265:04 pmRNSTransaction in Own Shares and Total Voting Rights
16th Feb 20264:04 pmRNSUpdate on Morphic Medical Inc.
13th Feb 20265:21 pmRNSTransaction in Own Shares and Total Voting Rights
12th Feb 20264:58 pmRNSTransaction in Own Shares and Total Voting Rights
11th Feb 20265:02 pmRNSTransaction in Own Shares and Total Voting Rights
10th Feb 20265:29 pmRNSTransaction in Own Shares and Total Voting Rights
9th Feb 20265:40 pmRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20266:24 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Feb 20265:59 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Feb 20266:20 pmRNSTransaction in Own Shares and Total Voting Rights
30th Jan 20265:30 pmRNSTotal Voting Rights
29th Jan 20265:18 pmRNSTransaction in Own Shares and Total Voting Rights
29th Jan 202610:38 amRNSMonthly Net Asset Value
27th Jan 20269:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20265:21 pmRNSTransaction in Own Shares and Total Voting Rights
19th Jan 20266:17 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jan 202612:32 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jan 202612:18 pmRNSReplacement: Update and corrections regarding TVRs
16th Jan 20267:00 amRNSReplacement: Transaction in Own Shares and TVR
16th Jan 20267:00 amRNSUpdate & corrections regarding total voting rights
12th Jan 20265:46 pmRNSCancellation of treasury shares
6th Jan 20265:18 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jan 20265:31 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Dec 20251:30 pmRNSTotal Voting Rights
31st Dec 20251:30 pmRNSTotal Voting Rights
29th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Dec 20254:48 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.